Vanderbilt University Medical Center: New Study Supports Remdesivir as COVID-19 Treatment
July 10, 2020
July 10, 2020
NASHVILLE, Tennessee, July 10 -- Vanderbilt University Medical Center issued the following news:
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported (https://www.sciencedirect.com/science/article/pii/S2211124720309219) that remdesivir . . .
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the fight against COVID-19, keeps getting better.
This week researchers at Vanderbilt University Medical Center (VUMC), the University of North Carolina at Chapel Hill and Gilead Sciences reported (https://www.sciencedirect.com/science/article/pii/S2211124720309219) that remdesivir . . .